Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study

被引:0
|
作者
Ronnie Kasirye
Heiner Grosskurth
Paula Munderi
Jonathan Levin
Zacchaeus Anywaine
Andrew Nunn
Anatoli Kamali
Kathy Baisley
机构
[1] MRC/UVRI Uganda Research Unit on AIDS,School of Public Health
[2] London School of Hygiene and Tropical Medicine,undefined
[3] University of Witwatersrand,undefined
[4] MRC Clinical Trials Unit at University College London,undefined
来源
关键词
Malaria; CD4; Antiretroviral therapy; Cotrimoxazole; HIV;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
    Bigna Jean Joel R
    Plottel Claudia S
    KoullaShiro Sinata
    贫困所致传染病(英文), 2016, 5 (05) : 87 - 88-89-90-91-92
  • [32] Linear Mixed Modeling of CD4 Cell Counts of HIV-Infected Children Treated with Antiretroviral Therapy
    Anjullo, Belay Belete
    Teni, Derbachew Asfaw
    ADVANCES IN PUBLIC HEALTH, 2021, 2021
  • [33] The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy
    Paton, N. I.
    Sangeetha, S.
    Earnest, A.
    Bellamy, R.
    HIV MEDICINE, 2006, 7 (05) : 323 - 330
  • [34] Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
    Bigna, Jean Joel R.
    Plottel, Claudia S.
    Koulla-Shiro, Sinata
    INFECTIOUS DISEASES OF POVERTY, 2016, 5
  • [35] CD4 TCR Vβ repertoire reconstitution in chronically HIV-infected children on antiretroviral therapy (ART)
    Kharbanda, M
    Sun, M
    Chitnis, V
    Bakshi, S
    Pahwa, S
    FASEB JOURNAL, 2001, 15 (05): : A1009 - A1009
  • [36] Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
    Jean Joel R. Bigna
    Claudia S. Plottel
    Sinata Koulla-Shiro
    Infectious Diseases of Poverty, 5
  • [37] The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy
    Edelman, E. J.
    Gordon, K. S.
    Tate, J. P.
    Becker, W. C.
    Bryant, K.
    Crothers, K.
    Gaither, J. R.
    Gibert, C. L.
    Gordon, A. J.
    Marshall, B. D. L.
    Rodriguez-Barradas, M. C.
    Samet, J. H.
    Skanderson, M.
    Justice, A. C.
    Fiellin, D. A.
    HIV MEDICINE, 2016, 17 (10) : 728 - 739
  • [38] Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users
    Wood, E
    Montaner, JSG
    Yip, B
    Tyndall, MW
    Schechter, MT
    O'Shaughnessy, MV
    Hogg, RS
    ANTIVIRAL THERAPY, 2004, 9 (02) : 229 - 235
  • [39] CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients:: the role of intravenous drug use
    Dronda, F
    Zamora, J
    Moreno, S
    Moreno, A
    Casado, JL
    Muriel, A
    Pérez-Elías, MJ
    Antela, A
    Moreno, L
    Quereda, C
    AIDS, 2004, 18 (16) : 2210 - 2212
  • [40] Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade
    Wolday, Dawit
    Kebede, Yazezew
    Legesse, Dorsisa
    Siraj, Dawd S.
    McBride, Joseph A.
    Kirsch, Mitchell J.
    Striker, Robert
    PLOS ONE, 2020, 15 (05):